Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.45 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | GLS2 | Q9UI32 | 3/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250641 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL29663659 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL10903572 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL4445122 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL11483358 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL11491808 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL5136501 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL8607905 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL11492302 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 | |
| SCHEMBL5930492 | 0.90 | SMPD1 (0.52) | SMPD1PRKCAFAAHGPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130165685-A1 | SYNTHESIS OF OMEGA-AMINO CARBOXYLIC ACIDS AND THEIR ESTERS FROM UNSATURATED FATTY ACID DERIVATIVES | EVONIK DEGUSSA GMBH (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20130165685-A1 | SYNTHESIS OF OMEGA-AMINO CARBOXYLIC ACIDS AND THEIR ESTERS FROM UNSATURATED FATTY ACID DERIVATIVES | EVONIK DEGUSSA GMBH (DE) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165685-A1 | SYNTHESIS OF OMEGA-AMINO CARBOXYLIC ACIDS AND THEIR ESTERS FROM UNSATURATED FATTY ACID DERIVATIVES | ALOX5, FASN, ALOX15 | SMPD1 2226/4885PRKCA 2373/4885FAAH 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.